Invention Grant
- Patent Title: Musculoskeletal stem cell and medium for inducing differentiation of musculoskeletal stem cell
-
Application No.: US16392524Application Date: 2019-04-23
-
Publication No.: US10576106B2Publication Date: 2020-03-03
- Inventor: Myung-Kwan Han
- Applicant: CELLATOZ THERAPEUTICS, INC.
- Applicant Address: KR Gyeonggi
- Assignee: Cellatoz Therapeutics, Inc.
- Current Assignee: Cellatoz Therapeutics, Inc.
- Current Assignee Address: KR Gyeonggi
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: KR10-2017-0139143 20171025
- Main IPC: A61K35/34
- IPC: A61K35/34 ; C12N5/0775 ; A61P21/00 ; A61K35/32 ; C12N5/00 ; C12N5/0735 ; C12N5/077 ; C12N5/074
Abstract:
The present disclosure relates to a novel musculoskeletal stem cell (MSSC) differentiated from an ESC (embryonic stem cell) or an iPSC (induced pluripotent stem cell). The musculoskeletal stem cell of the present disclosure can be easily induced from a human embryonic stem cell or a human-derived pluripotent stem cell and can be effectively differentiated not only into bone but also into cartilage, tendon and muscle. Accordingly, it can be usefully used for prevention or treatment of various musculoskeletal diseases.
Public/Granted literature
- US20190247441A1 NOVEL MUSCULOSKELETAL STEM CELL AND MEDIUM FOR INDUCING DIFFERENTIATION OF MUSCULOSKELETAL STEM CELL Public/Granted day:2019-08-15
Information query
IPC分类:
